Endolyn-78, a membrane glycoprotein present in morphologically diverse components of the endosomal and lysosomal compartments: implications for lysosome biogenesis by unknown
Endolyn-78, a Membrane Glycoprotein Present 
in Morphologically Diverse Components of the 
Endosomal and Lysosomal Compartments: 
Implications for Lysosome Biogenesis 
Edward Croze, Ivan Emanuilov Ivanov, Gert Kreibich, Milton Adesnik, David D. Sabatini, 
and Melvin G. Rosenfeld 
Department of  Cell Biology and the Rita and Stanley Kaplan Cancer Center, New York  University School of  Medicine, New York 10016 
Abstract.  A  monoclonal antibody (2C5) raised against 
rat liver lysosomal membranes was used to identify a 
78-kD glycoprotein that is present in the membranes 
of both endosomes and lysosomes and,  therefore,  is 
designated endolyn-78.  In cultures of rat hepatoma 
(Fu5C8) and kidney cells (NRK), this glycoprotein 
could not be labeled with [3sS]methionine  or with 
[32p]inorganic  phosphate but was easily labeled with 
[35S]cysteine and  [3H]mannose.  Pulse-chase experi- 
ments and determinations of endoglycosidase H  (endo 
H) sensitivity showed that endolyn-78 is derived from 
a precursor of Mr 58-62 kD that is processed to the 
mature form with a tt/2 of 15-30 min.  The protein has 
a 22-kD polypeptide backbone that is detected after a 
brief pulse in tunicamycin-treated cells.  During a 
chase in the presence of the drug,  this is converted 
into an O-glycosylated product of 46 kD that despite 
the absence of N-linked oligosaccharides is effectively 
transferred to lysosomes. This demonstrates that the 
delivery of endolyn-78 to this organelle is not mediated 
by the mannose-6-phosphate  receptor (MPR). 
Immunocytochemical experiments showed that 
endolyn-78 is present in the limiting  membranes and 
the interior membranous structures of morphologically 
identifiable secondary lysosomes that contain the 
lysosomal hydrolase B-glucuronidase,  lack the MPR, 
and could not be labeled with c~-2-macroglobulin  at 
18.5°C,  a temperature which prevents appearance of 
endocytosed markers in lysosomes. 
Endolyn-78 was present at low levels in the plasma 
membrane and in peripheral tubular endosomes, but 
was prominent in morphologically diverse components 
of the endosomal compartment (vacuolar endosomes 
and various types of multivesicular bodies) which ac- 
quired o~-2-macroglobulin  at  18.5°C,  and frequently 
contained substantial levels of the MPR and variable 
levels of/3-glucuronidase.  On the other hand,  the 
MPR was very rarely found in endolyn-containing 
structures that were not labeled with ot-2-macroglob- 
ulin at the low temperature.  Thus,  the process of 
lysosomal maturation appears to involve the progres- 
sive delivery of lysosomal enzymes to various types of 
endosomes that may have already received some of the 
lysosomal membrane proteins.  Although endolyn-78 
would be one of the proteins added early to endo- 
somes, other lysosomal membrane proteins may be 
added only to multivesicular endosomes that represent 
very advanced stages of maturation. 
T  H~ biogenesis of a lysosome involves the joining of 
both luminal  and  membrane components to form a 
fully functional  mature organelle.  In most cell types, 
this process cannot be completely dissociated from the phe- 
nomenon of endocytosis that brings to the lysosome extracel- 
lular  material  internalized  at the cell surface.  The endocy- 
totic  route  involves  passage  of the  interiorized  material 
through  several types of endosomes that differ in their rela- 
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tive acidity  (Yamashiro and Maxfield,  1987),  biochemical 
composition (Mueller and  Hubbard,  1986;  Schmid  et al., 
1988), morphological  appearance,  and closeness to the plas- 
ma membrane or Golgi apparatus  (see Helenius et al., 1983; 
Pastan  and  Willingham,  1983;  Geuze et al.,  1984,  1985; 
Wall and Hubbard, 1985; Hopkins, 1986; Dunn et al., 1986; 
Schmid et al.,  1988). It is not clear, however (see Helenius 
et al.,  1983), whether the different kinds of endosomes rep- 
resent a  series  of permanent  structures  that  transfer  their 
luminal content from one to another, and ultimately  to lyso- 
somes (vesicle shuttle model), or represent successive matu- 
ration stages in a biochemical and morphological membrane- 
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endosomes into lysosomes (maturation model) (see Helenius 
et al.,  1983;  Sahagian, 1984; Brown et al.,  1986; Grifliths 
et al., 1988). In any case, it is known that lysosomal hydro- 
lases are brought to lysosomes or prelysosomes from the 
trans-Golgi  network (TGN)'  (see Grittiths and Simons,  1986) 
by  clathrin-coated  vesicles  (Friend  and  Farquhar,  1967; 
Schulze-Lohoff  et al., 1985; Brown et al., 1986; Lemansky 
et al., 1987) in which the enzymes are bound to an integral 
membrane protein carrier, the mannose-6-phosphate recep- 
tor (MPR), that is capable of functioning in multiple cycles 
of  hydrolase  delivery  (see  Kornfeld,  1987).  Significant 
amounts of the receptor,  however,  are  not present in the 
membrane of the  mature  lysosome (Geuze et al.,  1984, 
1985; Brown et al., 1986; Griffiths et al., 1988). In the matu- 
ration model, the MPR, as well as the lysosomal hydrolases 
and membrane proteins, would be expected to be present in 
endosomes and the  removal of the receptor from mature 
lysosomes would simply represent the completion of the 
maturation process. In a vesicle shuttle model that takes into 
account the absence of the MPR from lysosomes, on the 
other hand, the hydrolases would be brought by the receptor 
to a permanent prelysosomal compartment where they could 
be packaged together with the lysosomal membrane proteins 
into an organelle from which the MPR is excluded. Recently, 
an apparently stable prelysosomal structure was described 
(Grifliths et al.,  1988) that contains lgp  120, a membrane 
protein characteristic of lysosomes (Lewis et al., 1985), and 
large amounts of the MPR. Since endocytosed material was 
found in this structure it was proposed that it represents a 
specialized endosome from which lyososomes already con- 
raining the endocytosed material must emerge. 
In the maturation model for lysosome biogenesis, mem- 
brane proteins of the mature lysosome are derived from the 
late endosome but may reach  this  organdie by different 
routes. Some proteins may, in principle, be brought together 
with the lysosomal hydrolases in vesicles derived from the 
Golgi apparatus.  Others may be contributed by the mem- 
branes of early endosomes and could, therefore, represent 
either plasma membrane proteins that were interiorized to- 
gether with extracellular material or distinctive components 
of endosomes which are not derived from the cell surface 
(Schmid et al.,  1988).  Finally, some lysosomal membrane 
proteins that apparently are not found in endosomes (Lewis 
et al.,  1985; Green et al.,  1987) could reach the lysosome 
by direct transfer from the TGN, independently of the lyso- 
somal hydrolases. 
To elucidate the pathways by which membrane proteins are 
incorporated into lysosomes, it is necessary to identify in- 
dividual lysosomal membrane proteins, to determine their 
distribution within different components of the cellular en- 
domembrane system, and to directly follow the routes that 
these proteins take to reach the lysosome. Recently, through 
the use of monoclonal or polyclonal antibodies raised against 
purified lysosomal membrane fractions, several  lysosomal 
membrane proteins have been identified, and aspects of their 
biosynthesis, their subcellular localization, and pathways of 
delivery to the lysosome have been studied (Reggio et al., 
1. Abbreviations used in this paper: Endo H, endo-/~-N-acetyl-glucosamini- 
dase; MPR, mannose-6-phosphate  receptor; MVBs, multivesicular bodies; 
O-glycanase,  endo-u-N-acetyl-galactosaminidase;  TGN,  trans-Golgi  net- 
work. 
1984; Chen et al., 1985a,b; Lewis et al., 1985; Tougard et 
al.,  1985;  D'Souza and August, 1986;  Brown et al.,  1986; 
Barriocanal  et  al.,  1986;  Lippincott-Schwartz and  Fam- 
brough,  1986, 1987; Green et al.,  1987; Grittiths et al., 
1988).  In general, these are all glycoproteins with a high 
content of complex carbohydrate chains that may serve to 
protect the polypeptides from proteolytic degradation in the 
lysosome. Some of these proteins have been reported to be 
also present at significant levels in the plasma membrane and 
in endosomes (Reggio  et al.,  1984;  Tougard et al.,  1985; 
Lippincott-Schwartz and Fambrough, 1986, 1987), whereas 
others have been reported to be essentially undetectable out- 
side lysosomes (Chen et al.,  1985b;  Lewis et al.,  1985; 
Green et al.,  1987). 
In  this  report,  we  describe  a  previously  unrecognized 
membrane glycoprotein, endolyn-78, which is present in sub- 
stantial amounts in lysosomes, as well as in endosomes, but 
is detectable only at low levels in the plasma membrane and 
the peripheral tubular endosomal compartment. Our find- 
ings suggest that lysosomal membrane proteins are first de- 
livered to endosomes, which are transformed into lysosomes 
not only by the acquisition of lysosomal hydrolases but also 
by a remodeling or maturation process that affects the protein 
composition of their limiting membranes. 
Materials and Methods 
Most reagents were purchased from Sigma Chemical Co. (St. Louis, MO), 
or from VWR Scientific (San Francisco,  CA).  [35S]Methionine (1,000 Ci/ 
mmol),  [35Slcysteine (1,000 Ci/mmol),  [32p]inorganic  phosphate (1  Ci/ 
mmol), 2-[3Hlmannose  (25 Ci/mmol), and Bolton-Hunter reagent (2,000 
Ci/mmol) were  purchased  from  New  England Nuclear (Boston,  MA). 
Trasylol was obtained from Mobay Chemical Corp.  (Pittsburgh,  PA); tuni- 
camycin from Calbiochem-Behring  Corp. (La Jolla, CA); sheep anti-mouse 
lgG,  rhodamine~conjugated  goat anti-mouse IgG,  and fluorescein-conju- 
gated goat anti-rabbit IgG from Cappel  Laboratories  (Cochranville,  PA); 
endo-/3-N-acetylglycosaminidase H (endo H) and neuraminidase from Boeh- 
ringer-Mannheim Biochemicals  (Indianapolis,  IN); and endo-~-N-acetyl- 
galactosaminidase  (O-glycanase)  was  purchased  from  Genzyme  Corp. 
(Boston, MA). DME, RPMI 1640, Kaighn's modified FI2, and horse, fetal 
calf, and calf sera were purchased from Irvine Scientific (Santa Ana, CA). 
Sprague-Dawley  female  rats (150-200  g)  were  obtained from  Taconic 
Farms, Inc. (Germantown,  NY) and Balb/c mice from the Jackson Labora- 
tory (Bar Harbor, ME). 
Isolation of  Lysosomes 
A highly purified fraction of lysosomes was prepared from rat liver by the 
method of Wattiaux et al. (1978) and the luminal content and peripheral pro- 
teins were removed by alkaline washing (Fujiki et al.,  1982). Trasylol (100 
U/ml), phenylmethylsulfonyl  fluoride (0.1 mM), leupeptin (0.5 #g/ml), and 
chymostatin (0.5/xg/ml)  were added to all solutions. 
Monoclonal Antibody Production 
For the production of monoclonal antibodies a fraction of alkaline-washed 
lysosomal  membranes containing 100 ttg protein was dissolved  in 0.5 mi 
PBS containing 0.5% SDS and 1% ~-mercaptoethanol,  boiled for 2-3 rain, 
and emulsified  with Freund's  complete adjuvant.  Female Balb/c mice re- 
ceived an initial intraperitoneal/subcutaneous  injection of 100 #g antigen 
with subsequent boosts, given every 4-6 wk for a period of 8 too, containing 
the antigen (100/~g) emulsified with incomplete Freund's adjuvant. 3 d after 
the final boost, the animals were killed, their spleens removed, dissociated, 
and a cell suspension prepared for fusion with P~UI myeloma cells accord- 
ing to the procedure of the St. Groth and Scheidegger  (1980). Cells were 
plated  in 96-well microtiter dishes and hybridomas secreting monoclonal 
antibodies recognizing  lysosomal  membrane proteins were identified  by 
ELISA (Cobbold and WMdmarm, 1981). Polyclonal antisera against/~-gluc- 
uronidase,  cathepsin D, or ribophorin I were prepared as previously  de- 
scribed (Rosenfeld et al.,  1982; Marcantonio et al.,  1982). 
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The rat hepatocyte cell line, clone 9, and the hepatoma-derived Fu5C8 line 
were cultured at 37"C in an 5% CO2 atmosphere in Kaighn's modified FI2 
medium supplemented with 5 % fetal calf serum and antibiotics. NRK-52E 
cells (obtained from the American Type  Culture Collection, Rockville, 
MD) were  cultured at 37"C  in a  10% CO2 atmosphere in DME supple- 
mented with 5% calf serum and antibiotics. 
lmmunofluorescence Microscopy 
Clone 9 cells were plated on round glass coverslips  (#1, 12 ram) and fixed 
with 2 % formaldehyde in PBS for 30 min. Some coverslips were incubated 
with chloroquine (50 ILM) 2-3 h before fixation. After penncabilization  with 
0.2% Triton X-100, the coverslips were incubated overnight at 4"C with un- 
diluted hybridoma culture fluid containing monoclonal antibody, washed in 
PBS containing 0.2%  gelatin, and incubated with rhodamine-conjugated 
goat anti-mouse IgG. For double labeling, coverslips were subsequently in- 
cubated overnight  at 4"C with either rabbit anti-rat-fl-glucuronidase  or rab- 
bit anti-rat-cathepsin D (at 1:2,000 dilution), washed,  and then incubated 
with fluorescein-conjugated  goat anti-rabbit IgG. Coverslips were mounted 
in Gelvatol (Monsanto Co., St. Louis, MO) and examined with a Leitz Or- 
thoplan Microscope (E.  Leitz, Inc., Rocldeigh,  NJ) equipped with a Wild 
camera (Wild Heerbrugg Instruments, Inc., Farmingdale,  NY). 
Labeling and Preparation of  Cell Extracts 
Monolayers of NRK or Fu5C8 cells were grown in 35-mm dishes to a den- 
sity of '~5  ×  I06 cells per dish. Before labeling, the cultures were rinsed 
with cysteine-free RPMI and incubated in this medium for 1 h to allow for 
the depletion of the intracellular cysteine pool. They were then incubated 
with  [35S]cysteine (125  ttCi/ml)  in cysteine-free  medium  supplemented 
with 5% dialyzed  fetal calf serum for various times, and when necessary, 
the labeling period was followed by a chase in complete medium. In experi- 
ments using tunicamycin,  confluent cultures were incubated with this drug 
(4 ttg/ml) for 1 h in complete medium and for 1 h in cysteine-free medium 
containing tunicamycin  before adding [35S]cysteine (125 t~Ci/ml) and tuni- 
camycin.  After labeling, monolayers  were washed twice with Moscona's 
PBS (Moscona, 1961)  and scraped offthe dish into an SDS solution (20 mM 
Tris-HCl, pH 7.4, 2 % SDS). The samples were sonicated  10-20 s in a Soni- 
tier cell disruptor equipped with a microtip (Heat Systems-Ultrasonics,  Inc., 
Farmingdale,  NY), boiled for 2 min and centrifuged (2 rain at 15,000 g) in 
an Eppendorf table top centrifuge (model 5412; Brinkmann Instruments Co., 
Westbury, NY) to remove unsolubilized material. The supernatant was di- 
luted fourfold with 50 mM Tris-HC1 (pH 8.0), 190 mM NaCl, 6 mM EDTA, 
2.5%  Triton X-100, 0.02%  NAN3, and I00 U/ml Trnsylol (Solution A). 
For labeling oligosaccharides,  NRK cells preincubated for 20 min in 
DME glucose-free  medium were  labeled for 18 h at 37"C in DME sup- 
plemented with 0.25 mM glucose and [3H]mannose (100 #Ci/ml) and then 
chased for 1 h in isotope-free  medium. [32P]inorganic phosphate labeling 
was carried out as described (Lemansky et ai.,  1985). 
lodination of Cell Fractions 
Purified plasma membranes (Croze and Morre, 1984) and lysosomes  were 
extracted  with alkali,  sedimented, and resuspended in PBS.  The resus- 
pended samples, containing 500 ttg of protein, were iodirmted with 250 ttCi 
of Bolton-Hunter reagent as described by the manufacturer (New England 
Nuclear). Unincorporated iodine was removed by G-25 Sephadex column 
chromatography and  samples  containing 50,000  cpm of trichloroacetic 
acid-precipitable radioactivity  were analyzed by immunoprecipitation  and 
PAGE, as described below. 
Immunoprecipitation 
Cell extracts were incubated overnight at 4°C with either undiluted culture 
medium from a hybridoma or with IgG (5 #g/ml) purified from that medium 
by protein A-Sepbarose affinity chromatography  (Hjelm et al., 1972). After 
incubation, immunocomplexes  were recovered using protein A-Sepharose 
CL-4B beads as previously  described (Rosenfeld et al.,  1982). For reduc- 
tion-alkylation, immunoprecipitated  material was  treated  with  100 mM 
DTT before incubation with 30 mM iodoacetamide  for 1 h on ice. Samples 
were dialyzed overnight against PBS, concentrated in a Speed Vac (Savant 
Instruments, Inc., Hicksville,  NY) and solubilized in electrophoresis buffer 
(Laemmli,  1970) before  analysis  by SDS-PAGE. 
Endoglycosidase Digestion 
The protein recovered  by immunoprecipitation from [35S]cysteine-labeled 
NRK cells was eluted from protein A-Sepharose beads by boiling in 0.5% 
SDS for 4 min. For endo H digestion,  the superuatants  were diluted with 
1 M  citrate-phosphate buffer (pH 5.0) to a final concentration of 50 mM, 
adjusted  to 0.2% SDS, and incubated overnight at 37"C with 0.2 U/ml of 
the enzyme. For O-glycanase  digestion, immunoprecipitated  protein was 
eluted  with 0.5%  SDS,  1.0% NP-40,  25 mM EDTA,  1.0% /~-mercapto- 
ethanol, 100 mM NaP (pH 6.1), and incubated for 1 h at 3"/°C with neur- 
aminidase (1  U/ml) to remove  sialic  acid.  O-glycanase  (4 mU) was then 
added and incubation continued overnight at 3"/*C. All samples were ad- 
justed to 2.0%  SDS in Laemmli's buffer for analysis by SDS-PAGE. 
Subcellular Fractionation 
FuSC8 cells grown to confluency in 60-mm dishes, were labeled for 1 h with 
[35S]cysteine, and chased in complete medium  for 4  h.  The cells were 
scraped offthe dishes, recovered by centrifugation (1,000 g for 10 rain), and 
resuspended  in 1 ml of 0.25 M sucrose.  The resulting suspension was sub- 
jected to nitrogen cavitation (500 psi for 5 rain at 40C) and centrifuged for 
3 min at 750 g to remove unbroken cells and nuclei. 1 rnl of the postnuclear 
supernatant was mixed with 9 ml of 22% isoosmotic Percoll in a Ti 50 high 
speed ultracentrifuge  tube (Beckman Instruments, Inc., Palo Alto, CA). Af- 
ter centrifugafion  (100,000 g at 4"C for 25 min), fractions (0.3 ml) were col- 
lected and either used directly for analysis or frozen at -20"C. Aliquots 
were used to measure the activity of marker enzymes B-hexosaminidase 
(Lippincott-Schwartz  and Fambrough,  1986),  5'-nuclcotidnse  (Croze and 
Morre, 1984), oeglucosidnse (Michael and Korufeld,  1980), or for immu- 
noprecipitation  with antiendolyn-78 or antiribophorin  I antibody (Rosonfeld 
et al., 1984). Immtmoprecipitates  were analyzed by PAGE and fluorognaphy 
and fluorographs  were scanned with an LKB Instnm~nts, Inc. (Galthers- 
burg,  MD) ul~  densitometer. 
Receptor-mediated  Endocytosis  of  •-2-Macroglobulin 
NRK cells were incubated at 4°C for 60 rain in serum-free media containing 
.-2-macroglobulin conjugated  to 20-um gold particles.  The temperature 
was then raised to either 18.5°C for 30, 45, and 180 rain, or to 37°C for 
5,  10, 20, 90, and 180 rain. Samples were then washed with ice cold PBS 
and fixed for conventional  EM or for immunolabeling on frozen thin sec- 
tions as described below. 
lmmunogold Labeling  of  Frozen Thin Sections 
Pellets  of NRK or clone 9  cells were fixed  in formaldehyde  (2-3.5%)/ 
glutaraldehyde  (0.5-2%) mixtures in 0.1  M  sodium cacodylate (pH 7.4) 
buffer. Frozen thin sections (Tokuyasu,  1980),  were processed for single 
labeling of endolyn-78  using the monoclonal antibody 2C5,  followed by 
sheep anti-mouse IgG conjugated  to  10-um  colloidal gold particles.  In 
double-labeling experiments,  after labeling for 2C5,  the samples received 
either rabbit anti-rat B-glucuronidase  IgG or rabbit anti-MPR IgG, fol- 
lowed by protein A-gold (5 nm). Sections were postfixed in glutaraldehyde 
and osmium tetroxide, positively stained with aqueous  uranyl acetate Ova- 
nov, I. E., manuscript in prepmation), embedded in LR White resin (Lon- 
don Resin Co., Ltd.,  Rasingstoke,  Hampshire, England) as described by 
Keller et ai. (1984), and observed at 80 10,1 with a Phillips EM 301 electron 
microscope. 
Figure 1.  The  monoclonal antibody 
to 2C5  recognizes  a  78-kD  protein 
present  in  lysosomes  but  undetect- 
able in a plasma membrane fraction. 
Alkaline-washed  lysosomal  mem- 
branes (lane a) and a  plasma mem- 
brane fraction (lane b) isolated from 
rat liver were dissolved in PBS and 
the  samples  were  iodinated  with 
125I-Bolton-Hunter  reagent  before 
immunoprecipitation with the mono- 
clonal antibody 2C5. Immunoprecip- 
Rates were  analyzed by SDS-PAGE 
and autoradiography. 
Croze et al. Endolyn-78, a Membrane Protein of Endosomes and Lysosomes  1599 Figure  2.  Endolyn-78 is present in vesicular structures that contain lysosomal hydrolases and swell after choloroquine  treatment.  (a-d) 
Clone 9 rat hepatocytes were processed for double-labeling immunofluorescence,  with monoclonal antibody 2C5 (a and c) and either rabbit 
anti-rat/~-glucuronidase  (b) or rabbit anti-rat cathepsin D (d). Affinity-purified rhodamine-conjugated,  goat anti-mouse IgG (a and c) 
or fluorescein-conjugated, goat anti-rabbit IgG (b and d) were used as secondary antibodies. Many lysosomes, identified by their labeling 
with anti-/~-glucuronidase or anti-cathepsin  D (b and d, arrows), are also labeled with the monoclonal antibody 2C5 (a and c, arrows). 
However, the monoclonal antibody also labels many vesicles (presumptive endosomes) (a and c, arrowheads) that are not labeled or are 
only very weakly labeled with antibodies to either lysosomal hydrolase (b and d, arrowheads). (e and  f) Rat liver clone 9 cells were incubated 
in the absence (e) or presence (f) of chloroquine (50 #M for 2 h) and processed for immunofluorescence using the 2C5 monoclonal anti- 
body. Bar, 10 ttm. 
Results 
Supernatants of hybridomas generated by immunization of 
mice  with  a  purified  lysosomal  membrane  fraction  were 
screened  by  ELISA  for antibodies  that  recognize compo- 
nents of the lysosomal membrane. This yielded, in addition 
to antibodies that recognized a  120-kD protein (not shown) 
which  probably corresponds  to  the  lgp  120  described  by 
other investigators (Lewis et al.,  1985), several monoclonal 
antibodies that recognized a protein of 78 kD that appeared 
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membrane proteins (see Barriocanal et al., 1986). One of the 
monoclonal antibodies (2C5) that recognized the 78-kD pro- 
tein  (Fig.  1),  produced at high titers  in cell culture,  was 
selected for further studies. This antibody recognized the an- 
tigen in assays that are carried out under denaturing condi- 
tions,  such  as  Western blotting and  immunoprecipitation 
procedures, as well as in immunofluorescence with lightly 
fixed cultured cells, a test in which the native configuration 
of the protein is likely to be conserved. As shown in Fig. 1, 
the antigen recognized by this antibody is found in lysosomes 
but is not detectable in a plasma membrane fraction. 
The lysosomal location of the antigen recognized by the 
2C5  antibody  was  demonstrated  by  double-labeling  im- 
munofluorescence using rabbit antibodies to the lysosomal 
hydrolase /3-glucuronidase  or  cathepsin  D  to  label  lyso- 
somes. In a cell line of hepatocyte origin (clone 9), the 2C5 
monoclonal antibody labeled numerous cytoplasmic vesicles 
and vacuoles which were also labeled with the antibodies to 
the lysosomal hydrolases (Fig. 2, a-d). However, the mono- 
clonal antibody also labeled other vesicular structures dis- 
tributed throughout the cytoplasm, which did not contain de- 
tectable levels of the lysosomal hydrolases and are, therefore, 
likely to represent endosomes. That a large proportion of the 
antigen recognized by the 2C5 monoclonal antibody was, in- 
deed, present in the membranes of lysosomes, and probably 
also in the membranes of endosomes, was demonstrated by 
the fact that in ceils treated with chloroquine, a drug that 
increases intralysosomal and endosomal pH and leads to the 
swelling of these organelles (Brown et al., 1986),  the mono- 
clonal antibody labeled intensely the periphery of the swollen 
vacuoles (see Fig. 2, e and  f). The localization of the antigen 
recognized by 2C5 in lysosomes and endosomes was defini- 
tively established  by  immunoelectron microscopy experi- 
ments (see below). 
We propose that proteins present in both the endosomal 
and lysosomal membrane compartments be designated endo- 
lyns (endosomal and/ysosomal proteins) and, therefore, will 
refer to the 78-kD antigen recognized by the monoclonal an- 
tibody 2C5 as endolyn-78. 
Biochemical Characterization and Biosynthesis 
of  Endolyn-  T8 
To further characterize endolyn-78, NRK cells were metabol- 
ically labeled with various radiolabeled precursors, and im- 
munoprecipitates obtained from cell lysates with the 2C5 
monoclonal  antibody  were  analyzed by  SDS-PAGE.  En- 
dolyn-78  could  only  be  labeled  in  cells  incubated  with 
p~S]cysteine or [3H]mannose  but not in cells incubated with 
[35S]methionine or [32p]inorganic phosphate (Fig.  3 A).  In 
contrast, ribophorins I and II, ~glucuronidase, and a micro- 
somal esterase, all labeled much more intensely with methio- 
nine than with cysteine (not shown). Thus, endolyn-78  is a 
glycoprotein that appears to lack phosphate and has a high 
cysteine to methionine ratio. Although, when disulfide bonds 
in the immunoprecipitated proteins were reduced with DTT 
or mercaptoethanol, the antigen migrated in SDS gel elec- 
trophoresis as a band of 78 kD, a second band of ,',,166 kD 
was also frequently observed (Fig. 3 A, a and c). These 78- 
and  166-kD  bands probably represent monomeric and di- 
meric forms of the same protein since both were again ob- 
served when the material in either band was excised from the 
Figure 3. Endolyn-78  is a cysteine-rich  glycoprotein  with a low me- 
thionine content that exists in monomeric and dimeric forms. (A) 
NRK cells were incubated with [35S]cysteine  (lane a), [35S]methio- 
nine (lane b), [32P]inorganic phosphate (lane d) for 4 h, or [3H]- 
mannose (lane c) for 18 h, and endolyn-78  was immunoprecipitated 
from  the  detergent-solubilized cell  lysates. Immunoprecipitates 
were analyzed directly by SDS-PAGE and fluorography.  (B) NRK 
(lanes a and b) or Fu5C8 (lanes c and d) cells were labeled with 
[3sS]cysteine for 4 h and endolyn-78  was immunoprecipitated  from 
detergent-treated lysates. The immunoprecipitates  were either ana- 
lyzed directly (lanes a and c) by SDS-PAGE followed  by fluorogra- 
play or were treated with 100 mM DTT and alkylated with iodo- 
acetamide before analysis (lanes b and d). Note that the proportion 
of monomeric to dimeric forms recovered from the two cell types 
is different. 
gel, incubated at 37°C, and rerun under the same conditions. 
When, after reduction, the immunoprecipitated protein was 
alkylated to prevent reformation of any disulfide bonds, the 
relative amounts of the monomeric and dimeric forms were 
not affected but the electrophoretic mobility of each form 
was significantly reduced (Fig.  3 B). 
Its efficient labeling with [3H]mannose,  together with the 
known fact that other lysosomal membrane proteins are rich 
in carbohydrate (e.g., Lewis et al., 1985; Barriocanal et al., 
1986; Fambrough et al.,  1988), prompted us to undertake a 
more detailed analysis of the glycoprotein nature of endolyn- 
78. When cultured cells were pulse-labeled for 15 min with 
[35S]cysteine, immunoprecipitation yielded two closely mi- 
grating products of '~58 and 62 kD (Fig. 4 A). These were 
converted with a half life of <15 min to the mature mono- 
meric 78-kD  and dimeric  166-kD  forms (Fig.  4  B).  The 
58-  and 62-kD  precursors  contain large  amounts of high 
mannose oligosaccharide chains,  since endo  H  treatment 
converted them to a single polypeptide of '~25 kD (Fig. 4, 
A and B). This suggests that both precursors only differ in 
the extent of their N-glycosylation. 
The extensive glycosylation  of endolyn-78 was also appar- 
ent when the labeled protein was recovered from cells treated 
with tunicamycin, an inhibitor that blocks the acquisition of 
N-linked oligosaccharides.  After a 15-rnin pulse with [3~S]cys- 
teine, a labeled polypeptide of 22 kD was immunoprecipi- 
tated by the 2C5 antibody (Fig. 5 A).  The slight molecular 
mass difference between this polypeptide (22 kD) and that 
generated by endo H treatment from the pulse-labeled poly- 
Croze et al. Endolyn-78. a Membrane Protein of Endosomes and Lysosomes  1601 Figure 4. Recently synthesized endolyn-78  contains large amounts 
of N-linked  oligosaccharides.  (A)  Immunoprecipitates obtained 
with the 2C5 antibody from NRK cells labeled for 15 min with 
[35S]cysteine were analyzed directly  (lane a)  or after  treatment 
with endo H (lane b) by SDS-PAGE. (B) After labeling for 15 min, 
cultures were chased for the times indicated. Immunoprecipitates 
from cell lysates were analyzed as in A. 
peptide produced in control cells (25 kD, Fig. 4) can be attrib- 
uted to the presence in the latter of the proximal asparagine- 
linked N-acetylglucosamine moieties. During a chase period, 
the 22-kD polypeptide was converted with a t~12 <  15 min 
into a protein of 46 kD (Fig. 5 A). This conversion results 
from the  acquisition  of O-linked  oligosaccharide  chains, 
Figure 5. Endolyn-78  contains O-linked as well as N-linked oligo- 
saccharides. (A) NRK cells were pretreated with tunicamycin and 
labeled with [35S]cysteine  for 15 min, followed by a chase for the 
times indicated, with inhibitor still present.  Immunoprecipitates 
obtained from detergent lysates were analyzed by SDS-PAGE and 
fluorography. (B) NRK cells pretreated with tunicamycin were la- 
beled with [35S]cysteine  for 4 h in the presence of the inhibitor. 
Immunoprecipitated endolyn-78  was analyzed by SDS-PAGE  before 
(lane a) or after (lane b) treatment with O-glycanase. 
since treatment of the 46-kD protein with O-glycanase re- 
duced its electrophoretic mobility to 31 kD (Fig. 5 B). The 
difference in relative molecular mass between this polypep- 
tide and that produced during a brief pulse in cells treated 
with tunicamycin (22 kD) is likely to be due to the presence 
in the former of residual O-linked oligosaccharides, such as 
GlcNAc/~(1-3)-GalNAc-Ser/Thr  or  GalNAc-Ser/Thr,  that 
are not removed or are inefficiently removed, respectively, 
by the O-glycanase (Lamblin et al.,  1984). 
Based on the difference in  electrophoretic mobility be- 
tween the product that accumulates in the presence of tuni- 
camycin and the high mannose form of endolyn-78 found in 
briefly labeled normal cells, it can be estimated (Fambrough 
et al.,  1988) that the protein contains ~12-13 asparagine- 
linked oligosaccharides. It should be noted that these oligo- 
saccharides appear to play a role in the dimerization of endo- 
lyn-78 since the dimeric form was not observed in extracts 
from tunicamycin-treated cells (Fig.  5). 
The [3H]mannose-labeled oligosaccharide chains present 
in glycopeptides obtained by pronase digestion of the mono- 
meric and dimeric forms of mature endolyn-78 were ana- 
lyzed by concanavalin A-Sepharose chromatography and in 
both cases the predominant oligosaccharide structures were 
of the tri- and tetraantenary type (Krusius et al., 1976), with 
no high mannose oligosaccharide chains (results not shown). 
Recovery of Endolyn- 78 in a Lysosomal Fraction: 
Addition of N-Linked Oligosaccharides Is not 
Required for Targeting the Protein to Lysosomes 
The  subcellular  distribution  of endolyn-78 was  examined 
(Fig. 6 b) by isopycnic centrifugation in Percoll gradients, to 
separate lysosomes from endosomes and other organelles in 
extracts obtained from cells labeled for 1 h  with [35S]cys- 
teine and chased for 4 h. The distribution of labeled endolyn- 
78 was compared with that of early endosomes, labeled with 
Lucifer Yellow during a 5-min incubation in vivo, and of sev- 
eral marker enzymes characteristic of the plasma membrane 
(5'-nucleotidase),  endoplasmic  reticulum  (t~-glucosidase), 
and lysosomes (/~-hexosaminidase; Fig. 6 a). The lysosomal 
fraction, recovered at a  density of 1.069-1.082  g/ml,  con- 
mined the bulk of the ~-hexosaminidase activity and 50 % of 
the labeled immunoprecipitable endolyn. The remainder of 
the labeled endolyn-78 was distributed throughout the gra- 
diem, with a small peak (12% of the total) found at a density 
of 1.035-1.052  g/ml.  This region contained the endosomes 
that  had  recently ingested  Lucifer Yellow,  as  well as  the 
plasma membrane and endoplasmic reticulum fractions. To 
determine if N-linked oligosaccharides play a role in the tar- 
geting of endolyn-78 to lysosomes, an extract from cells la- 
beled in a similar manner but in the presence of tunicamycin 
was fractionated in a Percoll gradient (Fig. 6 b). It was found 
that the form of endolyn that lacks N-linked oligosaccharides 
had the same distribution as the normal product. It, there- 
fore, can be concluded that the sorting mechanism that ad- 
dresses endolyn-78 to lysosomes does not rely on the pres- 
ence of the mannose-6-phosphate marker or other features 
of the N-linked oligosaccharides. 
Electron Microscopic Localization  of Endolyn- 78 
The nature of the cytoplasmic structures containing endolyn- 
78 was examined in a cell line of hepatocyte origin (clone 9) 
The Journal of Cell Biology, Volume 108,  1989  1602 Q 
I 
o.o  Q 
i 
.__>  II 
ot~tL~  ^ 
x 
/ 
O 
0  t 
0  4  8  12  16  20  2-.4  28 
Fraction number 
Figure 6.  Recovery of endolyn-78 in a lysosomal fraction: tuni- 
camycin treatment does not prevent the incorporation of  newly syn- 
thesized endolyn-78 into lysosomes. (a)  Lysates of Fu5C8 cells 
were fractionated by centrifugation in isoosmotic Percoll gradients 
and 0.3-ml fractions were collected for analysis. The distributions 
of 5'-nncleotidase (o), ~-glucosidase (o), and B-hexosaminidase 
(zx), as markers for the plasma membrane, ER,  and lysosomes, 
respectively, are expressed as percent of total activity. The region 
containing endosomes, labeled in vivo by incubating the cells with 
Lucifer Yellow for 5 rain immediately before cell fractionation, is 
marked with a line segment 0  0. (b) Fu5C8 cells were labeled 
with [~sS]cysteine for 1 h in the presence (e) or absence (o) of 
tunicamycin and incubated for 4 h in chase medium. Cell lysates 
were fractionated as in (a) and the radioactivity in endolyn-78, re- 
covered by immunoprecipitation from each fraction,  was deter- 
mined by densitometric scanning of the exposed x-ray film. The 
isopycnic density (g/ml) across the gradient was calculated from the 
position of marker beads. 
after double labeling with rabbit antibodies to the lysosomal 
hydrolase/~-glucuronidase and the monoclonal antibody 2C5 
(Fig. 7). The distribution of both antigens is given in Table 
I, which shows that 48 % of the fl-glucuronidase and 35 % of 
the endolyn-78 were found in morphologically identifiable 
lysosomes. Most of these structures were labeled with both 
antibodies but, whereas ~-glucuronidase was mainly located 
in the luminal content, endolyn-78 was found on the inner 
aspect of the limiting membrane, as well as in the luminal 
content (Fig. 7, a and b). Vacuolar endosomes and vacuoles 
that because of their content of internal membrane vesicles 
could be designated as multivesicular bodies (MVBs), con- 
mined/]-glucuronidase in varying, but generally much lesser 
amounts (11% of  the total, see Table I) than lysosomes. These 
structures also contained endolyn-78 (23 % of the total, Table 
I), which in the MVBs was predominantly on the outer as- 
pects of the membranes of the interiorized vesicles (Fig. 7, 
c and d). Many small and medium-sized cytoplasmic vacu- 
oles  with  clear lumen,  presumably  vacuolar endosomes, 
were devoid of ~-glucuronidase (Fig. 7 g) or contained low 
amounts of this lysosomal hydrolase (Fig. 7, e and  f) but con- 
tained endolyn-78, in agreement with the observations made 
by double-labeling irnmunofluorescence (Fig. 2). Significant 
amounts of B-glucuronidase and endolyn (,~35 % of each, 
Table I) were also found in tubulovesicular elements near the 
Golgi apparatus and throughout the cytoplasm, but the two 
labels were rarely found in the same elements (not shown). 
Presence of  Endolyn-78 in Endosomes: Colocalization 
with Internalized ,-2-Macroglobulin 
To directly confirm the endosomal nature of the nonlyso- 
somal vacuolar structures containing endolyn-78, and to es- 
tablish the distribution of this protein within the structurally 
and functionally complex endosomal compartment, the dis- 
tribution of endolyn-78 was correlated with that of the endo- 
cytic marker  ot-2-macroglobulin (Table I)  in  NRK  cells, 
which express the et-2-macroglobulin receptor (Pastan et al., 
1977). 
The structures labeled by ot-2-macroglobulin-gold con- 
jugates  at  various  times  after  the  administration  of this 
marker are shown in Fig. 8. Within a few minutes after interi- 
orization in  coated pits  (Fig.  8  a),  the  ligand  was  found 
within branching narrow tubules (40-80 nm) (Fig. 8, b and 
c) or small vacuoles (0.3 #m) (Fig. 8, c and d), which pre- 
sumably correspond to the most peripheral region of the en- 
dosomal system (see Helenius et al., 1983; Hopkins, 1986). 
Soon thereafter (10 rain), the marker was also found in larger 
(0.5-0.8-#m) vacuoles, which were usually empty and were 
designated vacuolar endosomes. Some structures of  this type 
contained a few internalized membrane vesicles and may be 
regarded as incipient MVBs (Fig. 8 e). At these early stages 
the ligand remained closely apposed to the inner aspect of 
the limiting membranes or to the surface of the interiorized 
vesicles. At 20 min after administration, ~2-macroglobulin 
began to accumulate in the lumen of the vacuoles which, to 
a varying extent, were filled with small vesicles and tubules, 
as well as with more complex membranous structures and 
some amorphous material that may represent the result ofau- 
tophagy (Fig. 8, f  and g). Because of their time of labeling 
and location within the cell, and because the ligand was al- 
ready released from its site of attachment on the membrane, 
these structures may correspond to juxtanuclear or "late en- 
dosomes" (Helenius et al.,  1983; Hopkins,  1986). Because 
of their characteristic morphology, however, many of them 
could also be described as MVBs. At later times, ~-2-macro- 
globulin appeared in large membrane-bounded bodies (0.5- 
2.0 #m) with the dense and heterogeneous luminal content 
characteristic of secondary lysosomes (Fig.  8, g and h). 
The distribution of endolyn-78 in structures containing en- 
Croze et al. Endolyn-78, a Membrane Protein of Endosomes and Lysosomes  1603 Figure 7. Colocalization of endolyn-78 and/~-glucuronidase  in lysosomes and endosomes of clone 9 cells. Endolyn-78 was immunolocalized 
with 10-nm gold particles (arrows) and/~-glucuronidase  with 5-nm gold particles (arrowheads). (a and b) Typical lysosomes with an heter- 
ogenous content that includes vesicles, membrane whorls,  and multilameUar structures are labeled for endolyn-78 (arrows) in the limiting 
membranes, as well as internally./3-glucuronidase  (arrowheads) is found throughout the luminal  content of lysosomes. (c and d) In MVBs 
The Journal  of Cell Biology, Volume 108, 1989  1604 Table I. Distribution of  Endolyn- 78, /Y-Glucuronidase, MPR, and Endocytosed oe-2-Macroglobulin in Cultured Cells* 
TGN  +  Vacuolar 
Plasma  cytoplasmic  Tubular  endosomes  MVB/Ly 
Cell  Marker  Temperature  membrane  vesicles  endosomes  +  MVB  +  lysosomes  Total 
°C  %  %  %  %  %  n 
Clone 9  Endolyn-78  37.0  5  37  ~  23  35  1,998 
O-glucuronidase  37.0  5  36  ~  11  48  1,463 
NRK 
Endolyn-78  37.0  6  22  3  21  48  646 
18.5  16  27  2  19  36  607 
MPR  18.5  6  56  0  30  8  718 
c~-2-macroglobulin-  18.5  31  0  36  32  < 1  376 
gold conjugates  37.0  3  0  8  24  65  432 
* NRK cells were incubated with a-2-macroglobutin-gold conjugates (20 nm) for 3 h at either 37 or  18.5°C before fixation.  Clone 9 cells were fixed without 
prior incubation with ~-2-macroglobulin. Cells were processed for immunogold labeling on frozen thin sections to localize the different markers. For each marker, 
gold particles were counted over randomly selected areas and the percentage in each subcellular component was tabulated. 
The very low percentages found in this compartment are included in the TGN  +  cytoplasmic vesicles figures. 
docytosed o~-2-macroglobulin-gold conjugates (20 nm) was 
determined in NRK cells that had been incubated with the 
endocytic marker  for 20  min,  90  min,  or 3  h  and were 
processed for immunogold labeling using the 2C5 antibody, 
which was localized with a  second antibody conjugated to 
10-nm gold particles (Fig. 9). It was observed that the coated 
vesicles through which ot-2-macroglobulin enters the cell 
(Fig.  9  a),  and the  small peripheral  tubular elements in 
which it was found soon thereafter (not shown, but see Fig. 
10 that illustrates endocytosis taking place at 18.5°C),  con- 
mined very low amounts of endolyn-78  (Table  I).  Higher 
amounts  of this  antigen  were  found,  however,  in  larger 
vacuolar endosomes in which the c~-2-macroglobulin was 
still associated with the inner aspect of the vacuolar surface 
(Fig. 9, b and c). MVBs containing c~-2-macroglobulin  also 
contained substantial amounts of endolyn-78 in the surround- 
ing membranes, as well as in the interiorized membrane vesi- 
cles and tubules (Fig. 9, d-f).  As expected, in secondary 
lysosomes, where at later times a-2-macroglobulin appeared 
in large quantities, endolyn was present in both the periph- 
eral membrane and within the lumen (Fig. 9, f  and g). 
Endosomes can be operationally defined as those vacuolar 
structures which receive and accumulate an endocytic mark- 
er, such as o~-2-macroglobulin,  at low temperatures (18.5°C) 
that do not permit its entrance into lysosomes (Dunn et al., 
1980).  We found that in NRK cells incubated for 45 min at 
18.5°C  with  c~-2-macroglobulin,  90%  of the  endosomal 
structures that had received the tracer were tubules near the 
cell surface, which contained very low amounts of endolyn- 
78 (Fig. 10 a). After a longer incubation (3 h, Fig. 10, b-e), 
however,  typical vacuolar endosomes and MVBs that were 
located deeper in the cell and in aggregate represented '~50% 
of the structures labeled with c~-2-macroglobulin  contained 
19 % of the endolyn molecules (Table I).  The presence of 
endolyn-78 in these structures definitively established that 
this protein is a component of the endosomal compartment. 
Even after 3 h at 18.5°C, the endocytic marker was not pres- 
ent in morphologically identifiable lysosomes and only very 
rarely (<1%, Table I) it was found in a class of MVBs that, 
in  addition to  internalized vesicles,  contained membrane 
whorls or larger membrane inclusions (which may represent 
the result of autophagy) and,  for that reason,  are labeled 
MVB/Ly in Fig.  10, c and d. At this time, lysosomes and 
MVB/Ly together contained 36 % of the endolyn molecules 
(Table I). It should be noted (Table I) that the prolonged incu- 
bation at 18.5°C led to a significant increase in the percent- 
age of  endolyn molecules at the cell surface (from 6 to 16 %), 
which may be accounted for by a concomitant diminution in 
the percentage of endolyn molecules found in lysosomes. 
To obtain an insight into the process of lysosomal biogene- 
sis, it was of  interest to determine the distribution of  endolyn- 
78  with respect to the MPR,  which brings the lysosomal 
hydrolases to developing lysosomes. This was accomplished 
by  double  immunolabeling,  using  the  2C5  antibody  to 
endolyn-78  and an antibody to the 215-kD  MPR, in NRK 
cells  that had been  incubated with o~-2-macroglobulin  at 
18.5°C for 3 h. These conditions made it possible to distin- 
guish between the endosomal compartment, which at this 
temperature receives the tracer, and the lysosomal one, from 
which the tracer is excluded. In these cells, about half of the 
MPR molecules were present in tubulovesicular structures 
found near the Golgi apparatus,  probably TGN elements, 
endolyn-78 is found in the limiting membranes and in the interior vesicles (arrows). The extent of  labeling of individual MVBs with anti-~/- 
glucuronidase (arrowheads) is variable and some (d) show little labeling for the lysosomal enzyme (e, f, and g). Many vacuolar structures 
that, because of their size and mostly empty lumen, may correspond to early endosomes contain endolyn-78 (arrows) and either lack (g) 
or contain (arrowheads, e and f) low amounts of/~-glucuronidase. Bar, 0.1 #m. 
Croze et al. Endolyn-78,  a Membrane Protein of Endosomes and Lysosomes  1605 Figure 8.  Components of the endocytotic pathway followed by t~-2-macroglobulin-gold conjugates during their transfer to lysosomes in 
NRK cells. NRK cells were incubated at 37°C with c~-2-macroglobulin-gold  conjugates (20 nm) for varying amounts of time and the cells 
were fixed in glutaraldehyde and processed for routine transmission electron microscopy. At early times (5 rain, a-d) the label is present 
in coated pits (CP, a), branching narrow peripheral tubules (t, b and c) and small vacuoles, presumably early vacuolar endosomes (eE, 
d) which in limited areas of their membranes may still bear a fuzzy coat, presumably reflecting their recent fusion with a coated vesicle. 
In all these cases, the gold particles are closely apposed to the limiting membranes. At 10 min (e), gold particles are also found in larger 
endosomes and in MVBs in which the marker appears bound to internalized vesicles. At 20 rain (f), label is found also in the lumen 
of large vacuoles that contain internal vesicles, as well as more complex membranous structures and some amorphous material. At this 
(g, 20 min) and later times (h, 90 min), the label appears with increasing frequency in membrane-bounded bodies with the heterogenous 
morphology characteristic of secondary lysosomes (Ly). Bar, 0.2 #m. 
The Journal of Cell Biology,  Volume 108, 1989  1606 Figure 9.  Localization of endolyn-78 along the pathway of endocytosis of a-2-macroglobulin. NRK cells  incubated  at 37°C for 20 (a, b, 
d, and e) or 90 (c, f, and g) rain with a-2-macroglobulin-gold conjugates  (20 run) were fixed and processed for frozen thin sectioning, 
and immunolabeling  for endolyn-78 (10-nm gold particles)  as described in Materials  and Methods.  In both a and b small, probably coated, 
vesicles (large arrowheads) containing only ot-2-macroglobulin appear to be fusing with preexisting  endosomes. In a, the preexisting  endo- 
some contains only endolyn-78 (small arrowheads), whereas in b it contains both c~-2-macroglobulin (arrows) and endolyn-78 (small arrow- 
heads). In early vacuolar endosomes (b and c), particles  of  both sizes are predominantly associated with the limiting membrane from which 
tubules and small vesicles sometimes appear to bud internally. In late endosomes (d), which frequently contain some vesicles, and in typical 
MVBs (MVB, e), many c~-2-macroglobulin conjugates (arrows) are no longer bound to the limiting membrane. In these structures endolyn-78 
(small arrowheads) is associated  not only with the limiting membranes, but also with membranes of internalized  vesicles.  Lysosomes (Ly, 
land g), with characteristic  complex internal membraneous structures  contain large amounts of a-2-macroglobulin (arrows) in their lumen 
and endolyn-78 (small arrowheads) in the limiting  and interiorized  membranes.  Bar, 0.1 #m. Figure 10. Localization of endolyn-78  in the endosomal compartment of NRK cells that internalized c~-2-macroglobulin  at 18.5°C.  NRK 
cells incubated for 45 min (a) or 3 h (b-e) at 18.5°C with c~-2-macroglobulin-gold  conjugates (20 nm) were processed for immunolabeling 
of endolyn-78  (10-nm  gold particles). At 45 min (a) the endocytic marker, ~2-macroglobulin (arrows), was found primarily (•90%  of 
the c~-2-macroglobulin  labeled structures) in tubules (t) which are found near the cell surface and rarely contain endolyn-78 and, to a limited 
extent, in peripheral early endosomes (eE) which are usually labeled for endolyn-78 (arrowheads). By 3 h of c~-2-macroglobulin administra- 
tion, this endocytic marker (arrows) was still most abundant (*50% of the c~-2-macroglobulin-containing  structures) in peripheral tubules 
(t, d), but was also present in early vacuolar endosomes (eE, b) ('~26% of the labeled structures) and in many MVBs (MVB, c and e) 
(,~24% of the labeled structures). Even after 3 h of administration of c~-2-macroglobulin at 18.5°C, this marker was not present in morpho- 
logically identifiable lysosomes (Ly, e) that contain endolyn-78  (arrowheads). At this time, ~-2-macroglobulin was present in negligible 
amounts in MVB/Ly (c and d) that, however, contain endolyn-78 (arrowheads). These bodies may represent an advanced stage in the conver- 
sion of MVBs to lysosomes since, in addition to interiorized vesicles, they also contain larger membraneous structures and membrane 
whorls similar to those in typical lysosomes (see Ly, e). Bar, 0.2/~m. 
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of MPR (6 %) were found in the plasma membrane, but sub- 
stantial levels of the receptor (30 % of the total) were present 
in vacuoles and MVBs that contained endolyn-78 and, on the 
basis of having acquired a-2-macroglobulin at the low tem- 
perature (Fig. 11, Table I), could be defined as endosomes. 
As expected from previous observations (Geuze et al., 1984, 
1985;  Brown et al., 1986; Griffiths et al., 1988),  the MPR 
was found to be absent from or present at very low amounts 
in most typical lysosomes which did not acquire c~-2-macro- 
globulin but did contain endolyn-78.  Structures that resem- 
bled MVBs but contained some of the inclusions typical of 
lysosomes (MVB/Ly) and did not acquire a-2-macroglob- 
ulin at 18.5°C usually lacked the MPR or had very low levels 
of this receptor (Fig.  11 f). Altogether, the lysosomal and 
MVB/Ly compartments contained ~8 % of the MPR (Table 
I). In only rare instances, some of the MVB/Ly structures 
contained high concentrations of the MPR (Fig.  11 g) and, 
therefore, resembled the structures described by Griffiths et 
al.  (1988),  which were considered to represent a prelyso- 
somal compartment where lysosomal enzymes are first pack- 
aged with newly synthesized membrane glycoproteins into 
lysosomes. 
Discussion 
The lysosomal membrane proteins so far identified in a vari- 
ety of cell types from different animal species (Lewis et al., 
1985; Tougard et al.,  1985; Chen et al.,  1985a,b; D'Souza 
and August,  i986;  Barriocanal et  al.,  1986;  Lippincott- 
Schwartz and Fambrough,  1986, 1987; Fambrough et al., 
1988) are all highly glycosylated  glycoproteins bearing com- 
plex N-linked oligosaccharide chains. It has previously been 
noted (Barriocanal et al., 1986) that similarities in the sizes 
of their precursor and mature forms suggest that some of 
these proteins  (the  mouse protein  LAMP-l,  Chen et al., 
1985a;  the rat lgp 120, Lewis et al., 1985; LIMP-3, Barrio- 
canal et ai.,  1986;  and the chicken LEP-100,  Lippincott- 
Schwartz and Fambrough, 1986),  may represent equivalent 
gene products,  However,  only two of the previously de- 
scribed proteins of the lysosomal membrane were found to 
be present at significant levels in endosomes, as well as in 
lysosomes (Tougard et al.,  1985;  Lippincott-Schwartz and 
Fambrough, 1986, 1987), a property which is also shared by 
endolyn-78,  the lysosomal membrane protein described in 
this work. 
Endolyn-78 differs from other lysosomal membrane pro- 
teins not only on the basis of its size and that of its un- 
glycosylated polypeptide backbone, but also in that it con- 
tains a large proportion of O-linked oligosaccharide chains. 
The polypeptide backbone in endolyn-78, identified by label- 
ing for short times in tunicamycin-treated cells, has an M, 
of 22 kD and the addition of O-linked sugars, that are largely 
removable by treatment with O-glycanase, increased its ap- 
parent molecular mass to 46 kD. As has been suggested for 
the N-linked oligosaccharides of other lysosomal membrane 
proteins (Lewis et al.,  1985;  Barriocanal et al.,  1986),  it 
seems likely that the abundant O-linked moieties in endolyn- 
78 also play a role in protecting the protein from degradation 
within the lysosome. 
Another unique biochemical feature of endolyn-78  is its 
lack or low content of methionine. In fact, endolyn-78 could 
not be labeled with [35S]methionine, but was easily labeled 
with [35S]cysteine, which labeled the bulk of cellular pro- 
teins and several specific proteins much less efficiently than 
[35S]methionine. Finally, endolyn-78  appears to easily form 
dimers which,  in spite of the apparent abundance of cys- 
teine, do not result from intermolecular S-S bonds. Rather, 
they result from interactions requiring the presence of the 
N-linked carbohydrate chains, since the 46-kD form produced 
in tunicamycin-treated cells did not dimerize. Pulse-chase 
experiments revealed that the O-linked sugars in endolyn-78 
are incorporated into the protein with kinetics very similiar 
to that with which the high mannose N-linked oligosaccha- 
rides are converted into endo H-resistant, complex forms. 
This observation is in agreement with other reports on the 
synthesis  of glycoproteins  bearing  both  types  of sugars 
(Hanover et al., 1982; Johnson and Spear,  1983),  and with 
the Golgi membrane localization of the enzyme UDP-Gal- 
NAc:polypeptide transferase that adds proximal O-linked 
sugars (Abeijon and Hirschberg,  1987). 
The finding that O-glycosylation proceeds rapidly in tuni- 
camycin-treated cells indicates that N-glycosylation is not a 
prerequisite for O-glycosylation and that the transit of endo- 
lyn from the endoplasmic reticulum to the Golgi apparatus 
is not dependent on the addition of the N-linked sugars.  Al- 
though, like endolyn-78, lysosomal hydrolases are glycopro- 
teins, not only do they contain a lower proportion of their 
mass as sugars but they display an important difference in 
their oligosaccharide structure. Thus, most of the oligosac- 
charide chains in endolyn-78  are of the complex tri-  and 
tetraantenary types, whereas the lysosomal hydrolases con- 
tain primarily high  mannose biantenary oligosaccharides 
(Kornfeld and Kornfeld, 1985; von Figura and Hasilik, 1986). 
Immunoelectron microscopy showed that endolyn-78  is 
present in morphologically and immunocytochemically  iden- 
tifiable secondary lysosomes. In these organelles the antigen 
is found exposed not only on the inner face of the limiting 
membrane, but also on interior membranous structures that 
may represent either invaginations or interiorized vesicles 
derived from the limiting membranes. Endolyn-78, however, 
is also present in various components of the endosomal com- 
partment and in cytoplasmic vesicles.  A study of its distribu- 
tion in cells that were allowed to ingest the endocytic marker 
c~-2-macroglobulin,  at either 37°C or 18.5°C, revealed that 
endolyn-78  is present in vacuolar endosomes, in which the 
pH was not yet sufficiently  low to release the gold-conjugated 
c~-2-macroglobulin  ligand from its membrane receptor, as 
well as in late endosomes and MVBs, in which the ligand was 
found free in the lumen. The low but significant levels of 
endolyn-78  detected at the cell surface most likely reflect a 
dynamic equilibrium in which there is a low steady-state con- 
centration of the protein in the plasma membrane. In fact, 
a significant increase ("~2.6 times) in cell surface levels of 
endolyn-78  was observed in the cells that internalized a-2- 
macroglobulin  at  18.5°C.  Another  lysosomal-endosomal 
membrane protein, LEP-100, has been shown to be present 
at low concentrations in the plasma membrane, but to rapidly 
recycle between the lysosomal, endosomal, and plasma mem- 
brane compartments, and to appear at much higher levels at 
the cell surface when the cells are treated with chloroquine 
(Lippincott-Schwartz and Fambrough,  1987).  Endolyn-78, 
however, does not behave in this manner since plasma mem- 
brane levels of this protein were not significantly increased 
Croze et aL Endolyn-78,  a Membrane Protein of Endosomes and Lysosomes  1609 Figure 11. The MPR is present in endosomes that contain endolyn-78  and receive internalized c~-2-macroglobulin in NRK cells incubated 
with the endocytic marker at 18.5°C:  evidence for the conversion of endosomes and MVBs into lysosomes. NRK cells incubated at 18.5°C 
for 3 h with the endocytic tracer c~-2-macroglobulin  (20-nm gold particles,/arge arrows) were processed for double immunolabeling (a, 
b, and f) with anti-endolyn-78 (10-rim gold particles, arrowheads) and anti-MPR (5-rim gold particles, small arrows) or only for labeling 
with anti-MPR (c, d, e, and g). Endosomes, defined by the presence of o~-2-macroglobulin (large arrows) at 18.5°C with the morphological 
appearance of vacuoles (a) or MVBs (b) contain endolyn-78 (arrowheads), as well as the MPR (small arrows). On the other hand, morpho- 
logically identifiable lysosomes (Ly,  f) do contain endolyn-78 (arrowheads) but not c~-2-macroglobulin  or the MPR. The MPR (small ar- 
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tions). 
Our observations add further support to that provided by 
Brown et al. (1986) to a maturation model for lysosome bio- 
genesis (see Helenius et al.,  1983;  Hopkins et al.,  1986; 
Brown et al.,  1986) in which there is no sharp transition be- 
tween endosomes and lysosomes but in which endosomes 
(MVBs) are gradually convorted into lysosomes. Thus, en- 
dolyn-78  was  present  at  relatively high  concentrations in 
MVBs that acquired a-2-macroglobulin at 18.5°C and con- 
rained the MPR as well as variable amounts of the lysosomal 
hydrolase/~-glucuronidase. These multivesicular endosomes 
varied considerably in their size and content of internalized 
vesicles, which presumably reflects their different degrees of 
maturation. The presence of the lysosomal enzyme in these 
endosomal structures suggests that they, like lysosomes, may 
participate in intracellular digestion, as has been shown for 
the endosomes of macrophages (Diment and Stahl,  1985). 
Other large MVBs showed some of the properties of lyso- 
somes,  such  as  the  absence  of c~-2-macroglobulin  after 
prolonged incubation at  18.5°C and the presence of more 
extensive membranous inclusions that may result from au- 
tophagy. Since structures of this morphological appearance 
were found to contain/3-glucuronidase and generally lacked 
the MPR,  it is likely that they represent an even more ad- 
vanced stage in the conversion of multivesicular endosomes 
to lysosomes and, therefore, have been designated MVB/Ly. 
In the very rare instances, MVB/Ly-type structures were 
observed (i,e.,  structures that did not acquire a-2-macro- 
globulin at 18.5 °C) that contained high concentrations of the 
MPR. These structures may be equivalent to a recently de- 
scribed MPR-enriched "prelysosomal intermediate" that was 
found  to  also  contain  substantial  levels  of the  lysosomal 
membrane protein lgp 120 (Grifliths et al., 1988). However, 
in the specimens we studied, such structures could not repre- 
sent an obligatory intermediate in the biogenesis of the lyso- 
some, i.e., one in which lysosomal membrane proteins and 
hydrolases would first meet each other, since we found the 
MPR to be abundant and lysosomal hydrolases to be present 
in many other types of endosomes and MVBs to which c~-2- 
macroglobulin was delivered at 18.5°C.  The putative "prely- 
sosomal  intermediate  ~ observed by Griffiths et al.  (1988) 
contained an extensive system of "thin,  wormlike tubules  ~ 
packed to high density inside its lumen.  We have not ob- 
served a structure with the same characteristics in our studies 
with the same cell line (NRK). It seems therefore likely that 
some of the MVBs and MVB/Ly described here may cor- 
respond to the "prelysosomal intermediate" of Griffiths et al. 
(1988), and that the differences in morphological appearance 
simply result from differences in sample preparation during 
fixation, cryomicrotomy, immunolabeling, or staining.  Never- 
theless, it remains to be determined why the putative inter- 
mediate described by Griffiths et al.  (1988), contained the 
bulk of the cellular complement of MPR,  whereas in our 
study MVBs containing the MPR but no a-2-macroglobulin 
at 18.5°C were only rarely observed. In fact, the bulk of the 
MPR was contained in structures that received c~-2-macro- 
globulin at 18.5°C and, therefore, were bona fide endosomes, 
as well as in tubulovesicular elements near the Golgi appara- 
tus and throughout the cytoplasm. This distribution is consis- 
tent with a  gradual conversion model in which endosomes 
acquire lysosomal enzymes brought by the MPR in Golgi- 
derived  vesicles,  while  undergoing  a  remodeling  of their 
membranes that ultimately leads to the complete removal of 
the MPR. 
The oligosaccharide chains of lysosomal hydrolases are es- 
sential for the targeting of the enzymes to lysosomes since 
they provide the sites for formation of the mannose-6-phos- 
phate recognition marker (see Kornfeld,  1987).  In contrast, 
endolyn-78,  like other lysosomal membrane proteins previ- 
ously described (Barriocanal et al.,  1986), is efficiently tar- 
geted to lysosomes even in tunicamycin-treated cells, in which 
the  mannose-6-phosphate  recognition  marker  cannot  be 
formed. The fact that lysosomal membrane components can 
reach the  lysosome independently of the  mannose-6-phos- 
phate recognition mechanism has been apparent from the ob- 
servation that some membrane-associated lysosomal hydro- 
lases,  such as ~-glucocerebrosidase (Erickson et al.,  1985) 
and acetyl-CoA (a-o-glucosamine N-acetyl transferase) (Korn- 
feld, 1987) are still present in lysosomes of fibroblasts from 
1-cell disease patients. The finding that lysosomal membrane 
proteins are incorporated into the organelle in the absence 
of the concomitant delivery of newly synthesized hydrolases, 
suggests that the conversion of an endosome into a lysosome 
could be effected by a membrane remodeling that does not 
require the constant delivery of packets of hydrolases from 
the TGN.  Alternatively, endosomes containing  the  newly 
synthesized membrane proteins could fuse with preexisting 
iysosomes. 
The maturation  model  of lysosomal biogenesis  implies 
that at least some endosomes, such as MVBs, are not perma- 
nent cellular structures and that the endocytosed material 
present in them is not simply transferred by shuttling vesicles 
to a lysosome. On the other hand, because of the high con- 
centrations of ligands that are observed in lysosomes, it is 
unlikely that during the maturation of endosomes to lyso- 
somes each  individual  endosome generates a  single  lyso- 
some. Rather, it is likely that vacuolar endosomes and later 
stage MVB-like endosomes undergo fusion with each other, 
followed by removal of excess membranes (probably by the 
formation of interiorized vesicles).  The capacity of endo- 
somes to fuse with each other (Braell, 1987; Gruenberg and 
Howell,  1987;  Salzman and Maxfield,  1988) and of lyso- 
somes to fuse with other lysosomes has been demonstrated 
(Ferris et al.,  1987; Deng and Storrie, 1988) and, in at least 
one case, evidence for endosome-lysosome fusion has been 
rows) is found throughout the endosomal compartment (defined by the presence of c~-2-macroglobulin)  (i.e., in peripheral tubular/vacuolar 
structures that contain ot-2-macroglobulin [large arrows, c], some of which are partially covered by a fuzzy coat similar to that in coated 
vesicles; in vacuolar endosomes with few internalized vesicles [d]; and in well-developed MVBs [el). Although most MVB/Ly (i.e, bodies 
that contain interiorized vesicles and membrane whorls but do not acquire c~-2-macroglobulin  at 18.5°C and presumably represent an ad- 
vanced stage in the conversion of an MVB to a lysosome) lack the MPR, in very rare instances bodies with the features of MVB/Lys (g) 
contain substantial amounts of MPR (small arrows).  Bar, 0.1 izm. 
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count for the concentration of endocytosed markers  in in- 
dividual lysosomes. 
Whereas our studies did not directly address the question 
of the pathway taken by  lysosomal  membrane  proteins to 
lysosomes,  it is clear that some lysosomal membrane pro- 
teins, such as endolyn-78, are already present in endosomes 
and that others,  such as  lgp  120,  which are not present at 
significant levels in endosomes (Lewis et al., 1985), must be 
added to them during the late stages of maturation, presum- 
ably by direct transfer from the Golgi apparatus or the TGN 
(Green et al., 1987). The fact that some membrane proteins 
are present in endosomes and not in lysosomes (Schmid et 
al.,  1988) implies that proteins are also removed from the 
endosomal membrane during the maturation process.  This 
is,  of course,  the case  for recycling receptors that are re- 
turned to the plasma membrane after releasing their ligands 
in the endosomal compartment (Geuze et al.,  1984,  1985), 
as well as for the MPR that brings the newly synthesized 
lysosomal  enzymes.  It  remains  to be  established  whether 
there is any "permanent"  endosomal  subcompartment that 
maintains a distinct composition of its own limiting mem- 
branes while it receives material endocytosed at the cell sur- 
face and transfers it to other endosomes that undergo conver- 
sion to lysosomes. 
The authors wish to dedicate this paper to the memory of Dr. E. D. P. De 
Robertis.  We thank Drs. Marilyn Farquhar and William Brown for their 
gifts of antibody to the MPR and Dr. Fred Maxfield for his generous gift 
of c~-2-macroglobulin.  We are grateful to Heide Plesken and Iwona Gumper 
for excellent technical assistance; Harriet E. Snitkin for her help in generat- 
ing the monoclonal antibodies; Jody Culkin for expert preparation  of the 
figures;  and Myrna Cort, Christina Saenz, and Bernice Rosen for typing 
the manuscript. 
This  work was supported by National Institutes  of Health Grant  GM 
20277.  M.  G.  Rosenfeld  is a recipient of a Whitehead Fellowship, 
Received for publication 24 August 1988 and in revised form 20 December 
1988. 
References 
Abeijon, C., and C. B. Hirschberg.  1987. Subcellular site of synthesis of the 
N-acetyl galactosamine (or 1-0) serine (or threonine) linkage in rat liver. J. 
Biol.  Chem. 262:4153-4159. 
Barriocanal, J. G., J. S. Bonifacino, L. Yuan, and I. V. Sandoval.  1986. Bio- 
synthesis, glycosylation, movement  through the Golgi system, and transport 
to lysosomes by an N-linked carbohydrate-independent mechanism  of three 
lysosomal integral  membrane proteins. J.  Biol. Chem. 261:16755-16763. 
Braell,  W. A. 1987.  Fusion between endocytic vesicles in a cell free system. 
Proc. Natl. Acad.  Sci. USA. 84:1137-1141. 
Brown, W. J., J. Goodhouse, and M. G. Farquhar.  1986.  Mannose-6-phos- 
phate receptors for lysosomal enzymes  cycle between the Golgi complex and 
endosomes. J.  Cell Biol.  103:1235-1247. 
Chen, J. W., W. Pan, M. P. D'Souza, and J. T. August. 1985a.  Lysosome- 
associated membrane proteins: characterization of LAMP-1 of macrophage 
P388  and  mouse embryo 3T3  cultured Cells.  Arch.  Biochem. Biophys. 
239:574-586. 
Cben, J. W., T. L.  Murphy, M.  C. Willingham, I.  Pastan, and J.  August. 
1985b.  Identification  of two lysosomal membrane glycoproteins. J.  Cell 
Biol.  101:85-95. 
Cobbold, B., and H. Waldmann. 1981. Rapid solid-phase enzyme-linked bind- 
ing assay for screening monoclonal antibodies to cell surface antigens. J. lm- 
munol. Methods. 44:125-133. 
Croze, E. M., and D. J. Morre.  1984.  Isolation  of plasma membrane, Golgi 
apparatus and endoplasmic reticulum fractions from single homogenates of 
mouse liver. J.  Cell Physiol.  119:46-57. 
Deng, Y., and B. Storrie. 1988. Animal cell lysosomes  rapidly exchange mem- 
brane proteins. Proc.  Natl. Acad. Sci. USA. 85:3860-3864. 
de St. Groth, F., and D. Scheidegger. 1980. Production of monoclonal antibod- 
ies:  strategy and tactics. J.  Immunol.  Methods.  35:1-21. 
Diment, S.,  and P.  Stahl.  1985.  Macrophage endosomes contain proteases 
which degrade endocytosed protein ligands. J.  Biol. Chem. 260:15311- 
15317. 
D'Souza, M. P., and J. T. August. 1986. A kinetic analysis of biosynthesis  and 
localization  of a lysosome-associated membrane glycoprotein. Arch. Bio- 
chem. Biophys.  249:522-532. 
Dunn, W. A., T. P. Connolly, and A. L. Hubbard.  1986. Receptor-mediated 
endocytosis of epidermal growth factor by rat hepatocytes: receptor path- 
way. J.  Cell Biol. 102:24-36. 
Dunn, W. A., A. L. Hubbard, and N. V. Aronson. 1980.  Low temperature 
selectively  inhibits fusion between pinocytic vesicles and lysosomes during 
heterophagy of ~2SI-Asialofemin  by the perfused rat liver. J.  Biol. Chem. 
255:5971-5978. 
Erickson, A. H., E. I. Ginns, and L  A. Barranger.  1985. Biosynthesis of the 
lysosomal enzyme/9-glucocerebrosidase.  J. Biol. Chem. 260:14319-14324. 
Fambrough, D. M., K. Takeyasu, J. Lippincott-Schwartz, and N. R. Siegel. 
1988. Structure of LEPI00, a glycoprotein that shuttles between lysosomes 
and the plasma membrane, deduced from the nucleotide  sequence of the en- 
coding eDNA. J.  Cell Biol.  106:61-67. 
Ferris, A. L., 1. C. Brown, R. D. Park, and B. Storrie.  1987. Chinese hamster 
ovary cell lysosomes rapidly  exchange contents. J.  Celt Biol.  105:2703- 
2712. 
Friend, D. S., and M. G. Farquhar. 1967. Functions of coated vesicles during 
protein absorption in the rat vas deferens. J.  Cell Biol. 101:357-376. 
Fujiki, Y., A. L. Hubbard, S. Fowler, and P. B. Lazarow.  1982. Isolation  of 
intracellular membranes by means of sodium carbonate treatment: applica- 
tion to endoplasmic reticulum. J.  Cell Biol. 93:97-102. 
Geuze, H.  J., J.  W.  Slot,  G. J.  A. M.  Strous, J.  Peppard,  K. yon Figura, 
A. Hasilik, and A. L. Schwartz. 1984. Intracellular receptor sorting during 
endocytosis: comparative immunoelectron microscopy of multiple receptors 
in rat liver. Cell. 37:195-204. 
Geuze, H. J., J. W. Slot,  G. J. A. M. Strous, A. Hasilik, and K. von Figura. 
1985.  Possible pathways for  lysosomal enzyme delivery.  J.  Cell Biol. 
101:2253-2262. 
Green, S. A., K. P. Zimmer, G. Grifliths, and I. Mellman. 1987. Kinetics of 
intracellular transport and sorting of lysosomal membrane and plasma mem- 
brane proteins. J.  Cell Biol.  105:1227-1240. 
Grifliths, G., and K. Simons. 1986.The trans-Golgi network: sorting at the exit 
site of the Golgi complex. Science  (Wash. DC).  234:438-443. 
Griffiths, G., B. Hoflack,  K. Simons, I. Mellman, and S. Kornfeld. 1988. The 
mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell. 52: 
329-341. 
Gruenberg, J., and K. E. Howell. 1987. An internalized  transmembrane  protein 
resides in a fusion-competent endosome for less than five minutes. Proc. 
Natl. Acad. Sci. USA. 84:5758-5762. 
Hanover, J. A., J. Eking, G. R. Mintz, and W. J. Lennarz.  1982. Tetdporal 
aspects of the N- and O-glycosylation of human chorionic gonadotropin. J. 
Biol.  Chem. 257:10172-10177. 
Harding, C., M. A. Levy, and P. Stahl.  1985. Morphological analysis of ligand 
uptake and processing: the role of multivesicular endosomes and CURL in 
reeeptor-ligand processing. Eur. J.  Cell Biol.  36:230-238. 
Helenius, A., I. Mellman, D. Wall, and A. Hubbard. 1983. Endosomes. Trends 
Biochem.  Sci. 8:245-250. 
Hjelm, H., R. Hjelm, and J. Sjoquist.  1972.  Protein A from Staphylococcus 
aureus. Its isolation by affinity chromatography and its use as an immunosor- 
bent for isolation ofimmunoglobulins.  FEBS (Fed. Fur. Biochem. Soc.  ) Len. 
1:73-76. 
Hopkins, C. R. 1986. Membrane boundaries involved in the uptake and intra- 
cellular  processing of cell  surface receptors.  Trends Biochem.  Sci.  11: 
473-477. 
Johnson, D., and P. Spear.  1983. O-linked oligosaccharides are acquired by 
herpes simplex virus glycoproteins in the Golgi apparatus. Cell. 32:987- 
997. 
Keller, G. A., K. T. Tokuyasu, A. H. Dutton, and S. J. Singer. 1984. An im- 
proved procedure for immunoelectron microscopy: ultrathin plastic embed- 
ding of immunolabeled ultrathin frozen sections. Proc.  Natl. Acad. Sci. 
USA. 81:5744--5747. 
Kornfeld, R., and S. Kornfeld. 1985. Assembly of asparagine-linked oligosac- 
charides. Annu. Rev. Biochem.  54:631-664. 
Kornfeld, S. 1987. Trafficking of lysosomal enzymes. FASEB (Fed. Am. Soc. 
Exp.  Biol.) J.  1:462-468. 
Krusius, T., J. Finne, and H. Rauvala. 1976. The structural basis of the differ- 
ent affinities  of two types of acidic  N-glycosidic glyeopeptides for con- 
canavalin A-Sepharose. FEBS (Fed. Eur. Biochem. Soc.) Lett. 71 : 117-120. 
Laemmli, U. K. 1970. Cleavage of structural proteins during assembly of the 
lead of bacteriophage T4. Nature  (Lond.). 227:680-685. 
Lamblin,  G.,  M.  Lhermitte,  A.  Klein,  P.  Roussel,  H.  van  Halbeek,  and 
J. F. G.  Vliegenthart.  1984.  Carbohydrate chains from human bronchial 
mucus glycoproteins: a wide spectrum of oligosaccharide structures. Bio- 
chem. Soc. Trans. 12:599-600. 
Lemansky, P., V. Gieselmann, A. Hasilik, and K. yon Figura. 1985. Synthesis 
and transport of lysosomal acid pbosphatase in normal and l-cell fibroblasts, 
J.  Biol. Chem. 260:9023-9030. 
Lemansky, P., A. Hasilik, K. von Figura, S. Helmy, J. Fishman, R. E. Fine, 
N. L. Kedersha, and L. H. Rome. 1987.  Lysosomal enzyme precursors in 
The Journal of Cell Biology, Volume 108,  1989  1612 coated vesicles derived from the exocytic and endocytic pathways. J.  Cell 
Biol.  104:1743-1748. 
Lewis, V., S. A. Green, M. Marsh, P. Vihko, A. Helenius, and I. Mellman. 
1985.  Glycoproteins of the lysosomal membrane. J.  Cell Biol.  100:1839- 
1847. 
Lippincott-Schwartz, J., and D. M. Fambrough. 1986. Lysosomal membrane 
dynamics: structure and  interorganellar movement of a  major lysosomal 
membrane glycoprotein. J.  Cell Biol.  102:1593-1605. 
Lippincott-Schwartz, J., and D. M. Fambrough. 1987. Cycling of the integral 
membrane glycoprotein,  LEPI00,  between plasma membrane and  lyso- 
somes: kinetic  and morphological analysis. Cell. 49:669-677. 
Marcantonio,  E.,  R.  Grebenau,  D.  D.  Sabatini,  and  G.  Kreibich.  1982. 
Identification  of ribophorins in rough microsomal membranes from different 
organs of several species. Eur. J.  Biochem.  124:217-222. 
Michael, J. M., and S. Kornfeld. 1980. Partial purification  and characterization 
of the glucosidases involved in the processing of asparagine-linked oligosac- 
charides. Arch.  Biochem.  Biophys.  199:249-258. 
Moscona, A. 196 I. Rotation-mediated histogenetic aggregation of dissociated 
cells. Exp. Cell Res.  22:455-475. 
Mueller, S. C., and A. L. Hubbard.  1986.  Receptor mediated endocytosis of 
asyaloglycoproteins by rat hepatocytes: receptor positive and receptor nega- 
tive endosomes. J.  Cell Biol. 102:932-942. 
Pastan,  I.,  and  M.  C.  Willingham.  1983.  Receptor-mediated endocytosis: 
coated pits, receptosomes and the Golgi. Trends Biochem. Sci. 8:250-254. 
Pastan, I., M. Willingham, W. Anderson, and M. Gallo.  1977.  Localization 
of serum derived alpha-2-macroglobulin in cultured cells and decrease after 
Moloney sarcoma virus transformation. Cell. 12:609-617. 
Reggio, H., D. Bainton, E. Harms, E. Coudrier, and D. Louvard. 1984. Anti- 
bodies against lysosomal membranes reveal a  100,000-mol-wt protein that 
cross-reacts with purified H+,K  + ATPase from gastric mucosa. J.  Cell Biol. 
99:1511-1526. 
Rosenfeld, M. G., G. Kreibich, D. Popov, K. Kato, and D. D. Sabatini.  1982. 
Biosynthesis of lysosomal hydrolases: their synthesis in bound polysomes 
and the role of co- and post-translational processing in determining their sub- 
cellular distribution. J.  Cell Biol.  93:135-143. 
Rosenfeld, M. G., E. E. Marcantonio, J. Hakimi, V. M. Ort, P. H. Atkinson, 
D. Sabatini,  and G. Kreibich. 1984. Biosynthesis  and processing of ribopbo- 
rins in the endoplasmic reticulum. 3".  Cell Biol. 99:1076-1082. 
Sahagian, G. G. 1984. The mannose-6-phosphate  receptor function. Biosynthe- 
sis and translocation. Biol. Cell. 51:207-214. 
Salzman, N., and F. Maxfield.  1988. Intracellular fusion of sequentially formed 
endocytic compartments. J.  Cell Biol.  106:1083-1091. 
Schmid, S. L., R.  Fuchs, P. Male, and L Mellman. 1988. Two distinct sub- 
populations of endosomes involved in membrane recycling and transport to 
lysosomes. Cell. 52:73-83. 
Schulze-Lohoff, E., A. Hasilik, and K. von Figura. 1985. Cathepsin D precur- 
sors  in clathrin-coated organeUes from human fibroblasts.  J.  Celt  Biol. 
101:824-829. 
Tokuyasu, K.  T.  1980.  lmmunocytochemistry on ultrathin frozen sections. 
Histochem. J.  12:381-403. 
Tougard, C., D. Louvard, R. Picart, and A. Tixier-Vidal.  1985.  Antibodies 
against a lysosomal membrane antigen recognize a prelysosomal compart- 
ment involved in the endocytic pathway in cultured prolactin cells. J.  Cell 
Biol.  100:786-793. 
von Figura, K., and A. Hasilik.  1986. Lysosomal enzymes and their receptors. 
Annu.  Rev. Biochem.  55:167-193. 
Wall,  D.  A., and A.  L.  Hubbard.  1985.  Receptor-mediated endocytosis of 
asialoglycoproteins by rat liver hepatocytes: biochemical characterization of 
the endosomal compartments. J.  Cell Biol.  101:2104-2112. 
Wattiaux, R., S. Wattiaux-Deconinck, M. F. Ronvcaux-Du Pal, and F. Dubois. 
1978. Isolation of rat liver lysosomes  by isopycnic centrifugation in metriza- 
mide gradients. J.  Cell Biol. 78:349-368. 
Yamashiro, D. J., and F. R. Maxfield.  1987. Acidification of morphologically 
distinct endosomes in mutant and wild-type  Chinese hamster ovary cells. J. 
Cell Biol.  105:2723-2733. 
Croze et al. Endolyn-78,  a Membrane Protein of Endosomes and Lysosomes  1613 